Quality Target Product Profile (QTPP) in Pharmaceutical Development

The Quality Target Product Profile (QTPP) is a prospective summary of the key quality characteristics that a drug product should achieve to ensure it consistently delivers the desired safety, efficacy, and patient acceptability.

It acts as the foundation of Quality by Design (QbD), guiding formulation and process development from the very beginning.

Purpose of QTTP

Provides a blueprint for product development.
Translates clinical and therapeutic needs into measurable pharmaceutical targets.
Helps identify Critical Quality Attributes (CQAs).
Ensures alignment with regulatory expectations (ICH Q8(R2), USFDA, EMA).
Supports lifecycle management by evolving as new knowledge is gained.

Typical Elements of a QTPP

Dosage form (tablet, capsule, injection, suspension, etc.)
Route of administration (oral, parenteral, topical, inhalation, etc.)
Dosage strength
Release profile (immediate, sustained, delayed release, etc.)
Pharmacokinetic requirements (bioequivalence, Cmax, Tmax, AUC)
Stability targets (shelf-life, storage conditions)
Quality attributes (assay, dissolution, impurities, uniformity, sterility)
Patient/healthcare usability (palatability, swallowability, device compatibility, ease of injection)

In short:

QTTP is the starting point of QbD, ensuring that every decision in development (excipients, process parameters, packaging, control strategy) is aligned with delivering a product that is safe, effective, stable, and acceptable.

The Quality Target Product Profile (QTPP) for a parenteral injection of Drug X defines it as a sterile aqueous solution for intravenous administration, with a strength of 100 mg/2 mL. The product must achieve systemic exposure equivalent to the reference drug with Cmax and AUC within bioequivalence limits. It should remain clear, isotonic, sterile, and free from visible or sub-visible particles, with a pH of 6.5–7.5. The injection is expected to maintain 95–105% assay and impurities within ICH limits for 24 months at 2–8 °C. To ensure usability and safety, it will be supplied as a ready-to-use pre-filled syringe.

Related Topics: